obesity-995x60.png
FEATURED ARTICLES
Why Operating Model Is The Next Competitive Frontier In Clinical Research Site Strategy – Part One
In this three-part series, Paradigm Clinical Research President Kurt Mussina discusses the meaningfulness of a site's operating model to clinical trial sponsors. In part one, he first defines operating model types.
-
![peptides-preclinical-develop-GettyImages-2264393871]( "Why Benchmarking Inflammatory Models Matters: What Early Human Data Tells Us")
Why Benchmarking Inflammatory Models Matters: What Early Human Data Tells UsBenchmarking immune challenge models clarifies early pharmacodynamic signals, helping teams distinguish true target engagement from variability, prioritize endpoints, and make confident decisions.
-
![assay plate, immunology, serology-GettyImages-1425761734]( "Expression Of Key Immunology Drug Targets In Human Inflammatory Challenge Models")
Expression Of Key Immunology Drug Targets In Human Inflammatory Challenge ModelsHuman challenge models reveal immune pathway behavior in controlled settings, linking early research to outcomes and helping confirm target engagement, refine dosing, and reduce development uncertainty.
-
![kaniel_cassady_01_edit_stairs]( "How One Researcher's Personal Study Experience Is Helping Him Better Serve Patients")
How One Researcher's Personal Study Experience Is Helping Him Better Serve PatientsRegeneron Executive Director in Clinical Sciences Kaniel Cassady, Ph.D., reflects on how his industry experience shaped his expectations, questions, and interactions as a patient in a clinical trial and how his patient experience is reshaping his clinical work going forward.
SERVICES AND PRODUCTS
Rapidly reduced timelines and waste, and the prevention of costly product shortages
In a world that is constantly changing, the development of innovative personalised medicine is helping more of us to live healthier lives for longer. These leaps forward in drug development create new hope for patients.
Yet operating high-value, time-sensitive supply chains naturally brings additional challenge and risk. Challenge and risk that require a step change in production approach to effectively balance patient-centricity with commercial viability.
Almac Trial Coordinator™ is a unified eClinical orchestration solution designed to simplify the execution of complex clinical trials. It brings together core trial functions including Interactive Response Technology (IRT), electronic Clinical Outcome Assessments (eCOA), eConsent, visit and participant management, and clinical supply oversight within a single, cohesive ecosystem.
Rather than operating as a collection of disconnected point solutions, Almac Trial Coordinator™ is designed to coordinate workflows, data, and users across the clinical trial lifecycle. The result is a more efficient, transparent, and site-friendly way to run global studies.
Boost patient engagement. Simplify and reduce site workload. Enable real-time, local currency payments through the patient’s preferred method.
Trial Enablement Solutions
Digital health technologies have the potential to transform clinical trials, yet without careful planning and operational support, their implementation can create complexity, increase site burden, and jeopardize data quality.
Backed by over 20 years of experience across nearly 300 industry-sponsored trials, Ametris’ Digital Health Operations team delivers end-to-end trial enablement services to ensure seamless technology deployment, reduce site burden, and capture reliable, high-quality data.
Ensure accurate, compliant, and impactful documentation with Altasciences' experienced medical writers and regulatory experts.
Accelerate trials with a centralized digital workspace that replaces manual documents, boosts collaboration, supports remote access, ensures compliance, and provides real-time visibility.